NCT02926729
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: Female
Age: 21 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patient must either be eligible and/or scheduled to undergo lumpectomy for breast cancer at Beth Israel Deaconess Medical Center
Exclusions: Patients that do not test tumors for ER, PR or HER2 status prior to surgery
https://ClinicalTrials.gov/show/NCT02926729